Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.50
+0.50 (0.71%)
At close: Dec 5, 2025
5.22%
Market Cap 3.51B
Revenue (ttm) n/a
Net Income (ttm) -117.07M
Shares Out 49.80M
EPS (ttm) -2.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,107
Average Volume 10,623
Open 69.90
Previous Close 70.00
Day's Range 68.10 - 70.90
52-Week Range 57.00 - 81.60
Beta -0.03
RSI 50.60
Earnings Date Nov 14, 2025

About Shine-On BioMedical

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.